GlobeNewswire

Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3
12/11/2026
PCAOB audited FY2024 and FY2025 and reviewed unaudited six months ended June 30, 2026 financials of G3 and its consolidated subsidiaries (“G3”) delivered In FY 2025, the Combined G3 company had consolidated revenue of $ [...]
Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference
12/11/2026
WAYNE, Pa., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials
12/11/2026
BD200 is a multibody drug conjugate, in which each arm of the antibody can alternatively bind to either Nectin-4 or Trop2, two validated oncology antigens that may be expressed on cancer cells Combined with a unique [...]
123Dentist CEO Jeff Leger and family establish fund at Dalhousie University’s Faculty of Dentistry to advance research into the connection between oral health and overall health
12/11/2026
The Leger Family Oral Health Research Fund will back research that deepens understanding of how oral health connects to overall health and chronic disease TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Jeff Leger, Chief [...]
Jeff Leger, président-directeur général de 123Dentiste, et sa famille créent un fonds à la Faculté de médecine dentaire de l’Université Dalhousie pour mieux comprendre le lien entre santé buccodentaire et santé globale
12/11/2026
Le Fonds de recherche en santé buccodentaire de la famille Leger soutiendra des travaux visant à mieux comprendre les liens entre la santé buccodentaire, la santé globale et les maladies chroniques TORONTO, 12 nov. 2026 [...]
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
12/11/2026
REVEAL pivotal and ASPIRE trials evaluating TSHA-102 for Rett syndrome ongoing; expect to report topline data from 6-month interim analysis and FDA feedback on BLA submission pathway in 1H 2027 TSHA-102 continues to be [...]
Fennec Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
12/11/2026
~ Third Quarter 2026 Net Product Sales of $19.4 Million, Up 56% Year over Year ~ ~ Third Quarter 2026 Non-GAAP Adjusted EBITDA of $5.8 Million ~ ~ With $6.7 Million in Positive Cash Flow from Operations, Cash Position [...]
Belite Bio Reports Unaudited Third Quarter 2026 Financial Results and Provides a Corporate Update
12/11/2026
New Drug Application (NDA) for tinlarebant in Stargardt disease type 1 (STGD1) granted priority review by the U.S. Food and Drug Administration (FDA) in August 2026 with Prescription Drug User Fee Act (PDUFA) target [...]
Human Appeal USA expands winter coat drive to six states
12/11/2026
Second annual campaign builds on 2,000 coats distributed in Baltimore last year, with plans to engage 40 collection partners and at least 300 volunteers MISSION VIEJO, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Human [...]
Rakovina Therapeutics Expands Strategic Engagement with Renowned AI Drug Discovery Pioneer Dr. Artem Cherkasov
12/11/2026
World leader in AI drug discovery to take on an expanded strategic advisory role, supporting AI drug discovery strategy, technology assessment and corporate development opportunities VANCOUVER, British Columbia, Nov. 12 [...]
A Race Against Blindness Unveils Classic 1989 Toyota Land Cruiser Fundraiser to Advance Vision Research
12/11/2026
Iconic FJ62 Land Cruiser returns with modern upgrades in a $125,000 prize package supporting research for inherited retinal diseases GILBERT, Ariz., Nov. 12, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness is bringing [...]
Commit Biologics nominates first development candidate from BiCE™, its complement system engaging platform, and strengthens senior leadership
12/11/2026
COM002 is a first-in-class complement-powered immune engager based on Commit Biologics’ proprietary BiCE™ platform. Anne-Marie Levy Rasmussen appointed Chief Operating Officer and Dr. Benjamin Ole Wolthers as Head of [...]
DaltonTx appoints Melissa Landon as Chief Commercial Officer to drive commercial growth and strategic partnerships
12/11/2026
Dr Landon brings 20+ years of experience in the application of AI/ ML to drug discovery She joins Dalton Tx to drive adoption of Dalton Tx ’s platform across pharma, biotech and CROs LONDON, Nov. 12, 2026 (GLOBE [...]
Evosep Appoints Scientia Life Technologies as Distributor in India
12/11/2026
Partnership gives India’s proteomics community more direct access to Evosep solutions, local expertise and support BHUBANESWAR, India , Nov. 12, 2026 (GLOBE NEWSWIRE) -- Evosep today announced the appointment of [...]
RAMSAY SANTE obtains approval from the Australian Securities Exchange for its foreign exempt listing in Australia
12/11/2026
REGULATORY INFORMATION Paris, November 12, 2026 Ramsay Santé obtains approval from the Australian Securities Exchange for its foreign exempt listing in Australia Ramsay Santé today announces that the Australian [...]
RAMSAY SANTE obtient l'approbation de l'Australian Securities Exchange pour sa cotation en Australie en tant qu'entité étrangère exemptée
12/11/2026
INFORMATION RÉGLEMENTÉE Paris le 12 novembre 2026 Ramsay Santé obtient l’approbation de l’ Australian Securities Exchange pour sa cotation en Australie en tant qu’entité étrangère exemptée Ramsay Santé annonce aujourd’ [...]
Mironid strengthens Board and clinical team to support next phase of growth
12/11/2026
Dr. Omar Khwaja joins the Board as Non-Executive Director Senior leadership team further strengthened with the appointments of Lars Erwig and Kimberly Hoffman Glasgow, Scotland, November 12, 2026 – Mironid, a [...]
Zealand Pharma Announces Financial Results for the First Nine Months of 2026
12/11/2026
Company announcement – No. 56 / 2026 Zealand Pharma Announces Financial Results for the First Nine Months of 2026 Advancing at pace towards Metabolic Frontier 2030: petrelintide in Phase 3, survodutide moving towards [...]
Santhera Signs Distribution Agreement with SteinCares for AGAMREE® (Vamorolone) in 31 countries across Latin America and the Caribbean
12/11/2026
Pratteln, Switzerland, November 12, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces it has signed an exclusive agreement with SteinCares for the distribution of AGAMREE® (vamorolone) for the treatment of Duchenne [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum